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Abstract
 
The diphtheria toxin A chain (DTA) was gene targeted into the Joining chain (J chain) locus to
create a mouse strain selecting against J chain–expressing cells, JDTA mice. Serum immuno-
globulin (Ig)M and serum IgG were reduced six to eightfold, while serum IgA was elevated
14-fold in these mice. JDTA mice were immune competent although the serum Ig response
compared with wild-type mice was reduced sixfold at day 14 but only fourfold at day 45 after
immunization. Exchanging the DTA gene with a cDNA for 
 
c-myc
 
 resulted in mice with a dis-
tinct phenotype with increased Ig production and enhanced humoral immune responses. Anal-
ysis of single B cells stimulated by lipopolysaccharide in vitro using reverse transcription–poly-
merase chain reaction showed that J chain–nonexpressing B cells could be detected that had a
secretory phenotype as determined by an abundance of transcript for secretory IgM. Finally,
limiting dilution analysis of peripheral B cells showed that J chain expression was a clonal prop-
erty already established in naive, peripheral B lymphocytes.
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Introduction
 
Humoral immunity is mediated by Igs that are secreted into
the body fluids and actively transported onto mucosal sur-
faces. In the serum, two types of Ig can be detected, so-
called natural antibodies and antigen-induced antibodies.
Natural antibodies (1–3) are mostly of IgM but also of IgG
or IgA isotype and the serum levels of these seems to be
controlled via a feedback mechanism (4, 5). Antigen-
induced antibodies are the end product of a humoral im-
mune response where antibodies of a given affinity and
specificity have been selected through intricate cellular
mechanisms (6, 7). Long-lasting serum Ig levels is an impor-
tant component in immunological memory through their
ability to neutralize viruses and other antigens on immediate
contact (8). The effector cell responsible for Ig production
into the body fluids is the plasma cell. Plasma cells can be
found in all secondary lymphoid organs, secreting Ig at a
high rate (9) and most of the serum Ig is derived from
plasma cells residing in the bone marrow (10–12). Plasma
cells have been believed to be short-lived, and to maintain
long-lasting serum antibody levels there consequently had
to be a continuous proliferation and differentiation of mem-
ory B cells into plasma cells (8, 13, 14). However, other re-
ports have shown that there are two distinct populations of
plasma cells that act as effectors of the humoral immune re-
sponse, short-lived and long-lived plasma cells (11, 12, 15,
16). Mucosal antibody responses are relatively short-lived
compared with serum antibody responses, which may be
due to either migration of plasma cells away from this site or
that plasma cells in these sites are short-lived (11, 17).
The Joining chain (J chain)
 
*
 
 is a glycoprotein that is asso-
ciated with pentameric IgM and dimeric IgA (18, 19). The
J chain is required to generate stable pentameric IgM and in
its absence IgM will be assembled into hexamers (18, 20).
In the case of IgA J chain is essential for the generation of
dimeric IgA and its transport onto mucosal surfaces, while
serum IgA is also present in a monomeric form that does
not contain the J chain protein (19). In the absence of J
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chain, IgA will neither interact with the poly-Ig receptor
nor form stable complexes with secretory component (21–
23). Mice where the J chain locus has been inactivated by
homologous recombination (24, 25) have an impaired
transport of IgA into the bile and over the intestinal mu-
cosa, while at other mucosal sites the transport of IgA
seemed unaffected (24, 26, 27). Furthermore, J
 
 
 
/
 
 
 
 mice
have elevated levels of IgA and unchanged IgG levels in se-
rum, while serum IgM levels are reduced and IgM immune
responses are compromised (25). Also, poly-Ig receptor–
deficient mice show an accumulation of serum IgA as well
as severely blocked transport of dimeric IgA across the in-
testinal mucosa (28, 29), further illustrating the biological
role for the J chain and the poly-Ig receptor.
In the mouse, the J chain is believed to be expressed in
plasma cells only, irrespective of the Ig isotype produced
(30, 31). However, several reports have indicated that hu-
man B cells initiate J chain expression at an earlier develop-
mental stage than shown for murine B cells. The J chain
gene was shown to be transcribed during both B and T
lymphopoiesis, but increased its expression as a function of
plasma cell differentiation. Similar results have been ob-
tained both in transformed B cell lines representing differ-
ent stages of B cell differentiation (32–34), and in sorted
hematopoetic subpopulations from human fetal and adult
tissues (35). Interestingly, J chain–like transcripts have also
been detected in species that lack Ig (36).
In humans, there has been reports indicating the pres-
ence of J chain-negative plasma cell populations. Thus,
only a fraction of IgA- and IgG-producing human B cells
stain positive for J chain using immunofluorescence (37–
39). In addition, a positive correlation between the produc-
tion of polymeric IgA and the presence of cytoplasmic J
chain was seen; tissues that produced predominantly mo-
nomeric IgA, like the bone marrow, generally displayed
fewer J chain-positive cells (37, 40). It has also been shown
that in secretory tissues such as salivary, mammary, and lac-
rimal glands, nasal and intestinal mucosa 
 
 
 
90% of the IgA
 
 
 
and 50–70% of the IgG-secreting cells were J chain-posi-
tive (39). We show here also in the mouse the presence of
two separate populations of B cells in vivo; one expressing J
chain and one that does not. The described experimental
system can be used to further explore the function of these
two B cell subsets.
 
Materials and Methods
 
Targeting Constructs and Embryonic Stem Cell Transfection.
 
The
mouse J chain gene locus was cloned from an I129 genomic
phage library and a targeting vector for gene replacement was
constructed as shown in Figs. 1 A and 6 A. The diphtheria toxin
A chain (DTA) subunit in a pUC plasmid (41) was given to us by
Ian H. Maxwell, University of Colorado Health Services Center,
Denver, Colorado. A 795-bp BglII fragment containing the DTA
gene (without its polyA sequence) or a 1.4-kb murine 
 
c-myc
 
cDNA fragment (a gift from Dr. Richard H. Scheuermann, Uni-
versity of Texas) was cloned 3
 
 
 
 of a 5-kb genomic fragment con-
taining the J chain promoter. An EcoRI/XhoI fragment from the
ploxPneo-1 plasmid containing the neomycin resistance gene
(neo
 
r
 
) under the control of the phosphoglycerate kinase promoter
and flanked by loxP sites was cloned 3
 
 
 
 of the DTA gene. A J
chain splice site was synthesized and cloned 3
 
  
 
of the neo
 
r 
 
gene af-
ter which a 10-kb KpnI/SalI fragment 3
 
  
 
of exon 1 was cloned.
The result was a construct where exon 1 of the J chain gene was
replaced by the DTA or the cMyc together with the neo
 
r
 
 gene.
The phosphoglycerate kinase promoter 
 
Herpes simplex
 
 thymidine
kinase gene was cloned into the polylinker 3
 
 
 
 of the J chain con-
struct. The whole construct was linearized by a unique NotI site
3
 
 
 
 of the thymidine kinase gene and transfected into the embry-
onic stem (ES) cell line E14 provided by Dr. Werner Muller, In-
stitute for Genetics, Cologne, Germany. Colonies were screened
by Southern blotting for homologous recombination events after
KpnI digestion and probed with an outside probe (see Figs. 1 A
and 5 A). A targeted JDTAneo clone was subsequently transiently
transfected with the plasmid pBS.Cre provided by Dr. Reinhard
Fassler, Lund University, to remove the neo
 
r
 
 gene, leaving only
one loxP sequence in the locus. Colonies that had lost their resis-
tance to G418 were expanded, DNA prepared and screened by
Southern blotting for removal of the neo
 
r
 
 gene (see Fig. 1 A). A
targeted JcMycneo clone was used to generate a mouse strain
which subsequently was bred to mice constitutively expressing
the Cre enzyme (42), enabling in vivo excision of the neo
 
r
 
 gene.
The thereby generated JcMyc mice were identified by Southern
blot analysis on DNA from tail biopsies (see Fig. 5 A).
 
ELISA.
 
To determine serum levels of the different Ig iso-
types we used goat anti–mouse IgA, IgM, or IgG antibodies as
coating antibodies (Southern Biotechnology Associates, Inc.) and
an horseradish peroxidase (HRP)-conjugated rabbit anti–mouse
Ig antibody (Dako) as secondary antibody. As a substrate we used
TMB (3,3
 
 
 
, 5,5
 
 
 
-tetramethylbenzidine; Sigma-Aldrich). The iso-
type-specific antisera were highly specific and did not cross-react
with purified proteins of other isotypes. To determine total serum
Ig levels we used a rabbit anti–mouse Ig antibody as a coating an-
tibody and an HRP-conjugated rabbit anti–mouse Ig antibody
(Dako) as secondary antibody.
 
Enzyme-linked Immunospot Assay.
 
To analyze the number of
cells secreting a specific isotype in different cell preparations we
performed an enzyme-linked immunospot assay (ELISPOT).
We used goat anti–mouse IgM, IgG, or IgA antibody as coating
antibody at 10 
 
 
 
g/ml (Southern Biotechnology Associates, Inc.).
After blocking, the cells were added to duplicate wells and incu-
bated for 4–5 h at 37
 
 
 
C. Cells were lysed and the debris removed
by washing in PBS/0.5% Tween. Biotinylated rabbit anti–mouse
IgM, IgG, or IgA was used as secondary antibody (Southern
Biotechnology Associates, Inc.) and the spots were developed
with AP-conjugated avidin (ExtrAvidin; Sigma-Aldrich) fol-
lowed by the substrate BCIP (5-bromo-4-chloro-3-indolylphos-
phate; Sigma-Aldrich). To analyze the number of Cholera toxin
(CT)-specific IgA-secreting cells after oral CT immunization we
performed a CT-specific ELISPOT assay (27). In brief, polysty-
rene petri dishes (Nunc A/S; Nunclon) were coated with 3
nmol/ml of GM1 ganglioside (Sigma-Aldrich) followed by an
additional incubation with 3 
 
 
 
g/ml CT (List Biological Labora-
tories) in PBS. After blocking, lamina propria (LP) lymphocytes
at 4
 
   
 
10
 
5
 
 were added to each petri dish and incubated for 4 h at
37
 
 
 
C. The cells were lysed and the debris removed by washing
in PBS/0.5% Tween. Single LP anti-CT–secreting cells were vi-
sualized by adding goat anti–mouse IgA as a primary antibody
(Cappel) and then a HRP-conjugated rabbit anti–goat Ig as a
secondary antibody (Dako A/S) followed by the substrate para-
phenylenediamine (Sigma-Aldrich). Spots were counted under
low magnification. 
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Western Blot Analysis.
 
Serum from wild-type (wt), JDTA
heterozygote (JDTA
 
 
 
/
 
 
 
), and homozygote (JDTA
 
 
 
/
 
 
 
) mice
were collected and IgA were purified with biotinylated goat anti–
mouse IgA (Southern Biotechnology Associates, Inc.) and
streptavidine Dynabeads (Dynal) according to the manufacturer’s
protocol. Electrophoresis was performed using a 5%, nondenatur-
ating polyacrylamide gel. Equal amounts of protein (0.2
 
  
 
g) was
loaded in each lane. The protein was transferred to a nylon mem-
brane (Hybond-C extra; Amersham Pharmacia Biotech) using a
Trans-blot SD system (Bio-Rad Laboratories). The filters were
blocked overnight in 5% dry fat-free milk in PBS-T, followed by
incubation with a rabbit anti–mouse IgA antibody (Zymed Labo-
ratories). HRP-conjugated donkey anti–rabbit Ig was used as sec-
ondary antibody (Southern Biotechnology Associates, Inc.), and
the filters were developed with ELC-reagent (Amersham Phar-
macia Biotech) according to the manufacturer’s protocol.
 
Cell and Intestinal Sample Preparations.
 
Spleen cells were re-
moved aseptically, single cell preparations made, counted, and
depleted of erythrocytes by treatment with Gey’s solution. LP
lymphocytes were prepared as described previously (27). In brief,
after thorough washing in Ca
 
2
 
 
 
- and Mg
 
2
 
 
 
-free HBSS (CMF-
HBSS; GIBCO BRL) the tissue pieces were incubated in CMF-
HBSS containing 5 mM EDTA to remove epithelial cells and
intraepithelial lymphocytes. The intestinal pieces were then incu-
bated in RPMI (GIBCO BRL) containing 300 U/ml collagenase
type C-2139 (Sigma-Aldrich) in order to enzymatically extract
the LP lymphocytes. The single cell suspension was washed three
times in CMF-HBSS and diluted to a final concentration of 2
 
  
 
10
 
6
 
 cells per milliliter in Iscove’s medium (GIBCO BRL) con-
taining 5% FCS (GIBCO BRL). Intestinal lavage samples for an-
tibody determinations were collected by a method adopted from
Elson et al. (43) described previously (27), and analyzed by ELISA
as described previously.
 
Mitogen Stimulation and Cell Fusion.
 
B cells were cultured in
RPMI (GIBCO BRL) supplemented with 7.5% FCS (Sigma-
Aldrich). LPS (
 
Escherichia
 
 
 
coli
 
 055:B5; Difco) was added at a final
concentration of 25 
 
 
 
g/ml. Cells for preparation of RNA were
harvested after 72 h of LPS stimulation. Fusion with Sp2/0 was
performed on day 2 LPS cultures, using 3.3 
 
  
 
10
 
6
 
 Sp2/0 cells and
16.5 
 
 
 
 10
 
6
 
 LPS-stimulated B lymphocytes. The fused cells were
resuspended carefully and plated on 96-well plates in three differ-
ent cell densities with regard to Sp2/0 cells; 20,000, 5,000, and
1,250 Sp2/0 cells per well. Conventional selection procedures
were used.
 
Reverse Transcription PCR Analysis.
 
RNA was prepared from
LPS-stimulated wt, JDTA heterozygote (JDTA
 
 
 
/
 
 
 
), JDTA, Jc-
Myc heterozygote (JcMyc
 
 
 
/
 
 
 
), and JcMyc splenocytes by the use
of “RNAzol™B” according to the manufacturer’s protocol (AMS
Biotechnology). cDNA was prepared by the use of “Superscript™
RNase H Reverse Transcriptase” according to the manufacturer’s
protocol (Life Technologies) and then used in PCR with the fol-
lowing primers. Primers used for detection of HPRT transcripts
were 5
 
 
 
-GCT GGT GAA AAG GAC CTC T-3
 
 
 
 located in the
5
 
  
 
end and 5
 
 
 
-CAC AGG ACT AGA ACA CCT GC-3
 
  
 
located
in the 3
 
  
 
end giving a PCR product from cDNA of 249 bp.
Primers used for detection of J chain transcripts were 5
 
 
 
-ATG
AAG ACC CAC CTG CTT CTC TGG-3
 
 
 
 located in exon 1
and 5
 
 
 
-AGG GTA GCA AGA ATC GGG GGT CAA-3
 
 
 
 lo-
cated in exon 4 giving a PCR product from cDNA of 470 bp.
Primers used for detection of transcripts between DTA and exon
4 in the J chain were 5
 
 
 
-TAT ATG GCT CAA GCC TGT G-3
 
 
 
located in the 3
 
  
 
end of the DTA gene and 5
 
 
 
-AGG GTA GCA
AGA ATC GGG GGT CAA-3
 
 
 
 located in exon 4 of the J-chain
gene giving a PCR product from cDNA of 650 bp. Primers used
for detection of transcripts between cMyc and exon 4 in the J
chain were 5
 
 
 
-GAC GAG CAC AAG CTC ACC TCT GAA-3
 
 
 
located in the 3
 
  
 
end of the cMyc gene and 5
 
 
 
-AGG GTA GCA
AGA ATC GGG GGT CAA -3
 
  
 
located in exon 4 of the J chain
gene giving a PCR product from cDNA of 560 bp. Primers used
for detection of secretory IgM were 5
 
 
 
-TGT GTG TAC TGT
GAC TCA CAG GGA-3
 
 
 
 located in exon 3 of the constant part
and 5
 
 
 
-AGG GAG ACA TTG TAC AGT GTG GGT-3
 
 
 
 lo-
cated in the secretory region giving a PCR product of 427 bp.
Primers used for detection of membrane bound IgM were 5
 
 
 
-
TGT GTG TAC TGT GAC TCA CAG GGA-3
 
 
 
 located in
exon 3 of the constant part and 5
 
 
 
-TGT AGA AGA GGC TCA
GGA GGA AGA-3
 
 
 
 located in the membrane exon M1 giving a
PCR product of 492 bp. PCR products were separated on aga-
rose gels, vacuum blotted to nylon filters (Zeta probe; Bio-Rad
Laboratories) and then hybridized with [
 
32
 
P]-labeled probes for
HPRT, IgM, and J chain as indicated.
 
Immunization and Analysis of Immune Responses.
 
Mice were
immunized intraperitoneally with the T cell–dependent antigen
2-phenyl-5-oxazolone coupled to OVA (phOx-OVA), 100 
 
 
 
g
alum precipitate per mouse at the age of 4 mo, five mice of each
genotype in each of two independent experiments. At indicated
days serum samples were collected and antigen-specific ELISAs
performed. Coating antigen was phOx coupled to BSA and a
HRP-conjugated rabbit anti–mouse Ig antibody (Dako) was used
as a secondary antibody. For the antigen-specific IgM, IgG, or
IgA ELISA, biotinylated goat anti–mouse IgM, IgG, or IgA
(Southern Biotechnology Associates, Inc.) were used as secondary
antibodies and developed by HRP-conjugated streptavidin
(Sigma-Aldrich). As a substrate we used TMB (3,3
 
 
 
,5,5
 
 
 
-tetra-
methylbenzidine; Sigma-Aldrich). Six mice of each genotype
were given three oral immunizations 10 d apart with 10 
 
 
 
g of
CT (List Biological Laboratories) in 6% (wt/vol) NaHCO
 
3
 
 in
PBS through a baby feeding tube under light ether anesthesia as
described previously (27). A CT-specific ELISA was performed
on serum and lavage from immunized mice as follows and as de-
scribed previously (27); microtiter plates were coated with 0.5
nmol/ml GM1 ganglioside (Sigma-Aldrich) followed by incuba-
tion with 0.5 
 
 
 
g/ml CT (List Biological Laboratories). As a sec-
ondary antibody we used HRP-conjugated goat anti–mouse Ig or
goat anti–IgA antibodies (Southern Biotechnology Associates,
Inc.) and as substrate ortho-paraphenylenediamine (Sigma-Aldrich).
Analysis of the number of CT-specific IgA-secreting cells in the
LP from immunized mice was performed using ELISPOT as de-
scribed previously.
 
Single Cell PCR Analysis.
 
Day 3 LPS-stimulated splenic cell
suspensions were incubated with biotinylated anti-B220 antibod-
ies (BD PharMingen), washed twice followed by incubation with
streptavidin Dynabeads (Dynal). Positive cells were harvested by
picking single cells in 0.8 
 
 
 
l drops of PBS under a light micro-
scope and then transferring them to RNase free tubes. Nested
single cell reverse transcription (RT)-PCR was performed by us-
age of “Titan™ one tube RT-PCR system” according to the
manufacturer’s protocol (Boehringer).
 
Limiting Dilution Analysis.
 
Spleen cells from normal wt
C57BL/6 mice were prepared as described previously. Splenic
lymphocytes were then seeded at 1, 3, 10, 30, 100, 300, and
1,000 cells per well in 96-well plates, one hole plate for each cell
density, in a total of 200 
 
 
 
l RPMI (GIBCO BRL) supplemented
with 7.5% FCS (Sigma-Aldrich), 1% IL-6 S/N, and 25 
 
 
 
g/ml
LPS (
 
E. coli
 
 055:B5; Difco). After incubation for 7 d, the super-
natants were collected and the dry plates frozen at 
 
 
 
80
 
 
 
C. We 
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performed a total Ig ELISA on the supernatants, as described pre-
viously, to detect Ig-secreting clones. The fraction of Ig-negative
wells from each plate was then plotted against the number of
seeded cells per well. This gave us, according to the Poisson dis-
tribution, the limit for clonality. From wells containing clonal
cultures, cDNA was prepared and analyzed with PCR for HPRT
expression and J chain expression. PCR products were separated
on agarose gels, vacuum blotted to nylonfilters (Zeta probe; Bio-
Rad Laboratories), and then hybridized with [
 
32
 
P]-labeled probes
for HPRT and J chain as indicated.
 
Results
 
Construction of the JDTA Mouse Strain.
 
To address di-
rectly whether a dichotomy of plasma cells could be distin-
guished based on J chain expression, we created a mouse
strain where J chain–expressing cells were selectively de-
pleted. We replaced the first exon in the mouse J chain
locus with the coding sequence for the DTA. It has previ-
ously been shown in transgenic models that the tissue-
specific expression of DTA can selectively deplete defined
cell populations (44–46) or indeed whole organs (41, 47).
The strategy for gene targeting in the J chain locus and sub-
sequent removal of the selection marker, enabling the ex-
ogenous gene to be expressed, is outlined in Fig. 1 A. A
DNA construct was made where exon 1 of the J chain gene
was replaced by the DTA gene. This was followed by the
neo
 
r
 
 cassette flanked by loxP sequences, where the splice
site of the J chain exon 1 was placed 3
 
  
 
of the neo
 
r 
 
gene.
Hence, no expression of DTA can occur until the neo
 
r
 
 cas-
sette has been removed. The construct was electroporated
into E14 ES cells and G418-resistant clones were screened
by Southern blot analysis. Homologous recombinant clones
were obtained at a frequency of 1/300 and mice derived
from such an ES cell clone had a J chain
 
 
 
/
 
 
 
 phenotype
(25). To activate the DTA gene, the ES cell clone used to
generate the J chain
 
 
 
/
 
 
 
 mice was transiently transfected
with a Cre expression plasmid to excise the neomycin cas-
sette (excised clones were obtained at a frequency of 1/12).
Figure 1. Replacement of the J chain exon 1 with
the DTA gene. (A) Disruption of the J chain gene and
gene replacement by homologous recombination. Ge-
nomic map of J chain locus before and after homolo-
gous recombination. Digestion with KpnI gives an en-
dogenous band of 5.6 kb while the recombined locus
gives a band of 8.0 kb for JDTAneo and 6.4 kb for
JDTA after removal of the neor gene. Southern blot
analysis of the recombined J chain locus showing wt,
heterozygous ( / ) JDTAneo, and heterozygous
( / ) JDTA using an outside probe (not present in
the construct used for targeting). E, EcoRI; B, BamHI;
S, SacI; P, PstI; K, KpnI; and H, HindIII. (B) Expres-
sion analysis by RT-PCR for J chain and DTA tran-
scripts in wt, JDTA heterozygous (JDTA / ), and
JDTA mice. Primers for J chain were located in exon 1
and in exon 4 of the J chain locus. Primers for DTA
transcripts were located in the 3  end of the DTA gene
and in the exon 4 of the J chain locus. Shown is also
analysis for HPRT transcripts as a cDNA control.561 Erlandsson et al.
Fig. 1 A also shows a Southern blot analysis of KpnI-
digested DNA from wt and heterozygous ES cells before
(JDTAneo) and after the removal of the neomycin cassette
(JDTA). No new integration of DNA into the genome
could be detected after the transient transfection with Cre,
as judged by Southern blot analysis and PCR analysis (data
not shown). Subsequently, ES cells where the neor cassette
had been removed were injected into blastocysts to gener-
ate chimeric mice, after which the JDTA mouse strain was
established by backcrossing these chimeras to C57BL/6
mice. Litter sizes of the JDTA mice were normal and the
offspring displayed a normal Mendelian distribution of wt,
heterozygous, and homozygous mice.
To assess the expression of the inserted DTA gene, we
performed RT-PCR analysis of RNA from splenocytes
stimulated with LPS during 4 d (Fig. 1 B). Activation of J
chain transcription could be detected in cells from both wt
and JDTA heterozygous mice and transcription of the tar-
geted JDTA locus was detected in both heterozygous and
JDTA mice. Within the sensitivity of the PCR assay it ap-
peared that JDTA heterozygous mice expressed higher lev-
els of JDTA transcripts than did JDTA mice, which could
be explained by that cell death occurs more rapidly in cells
that are homozygous for the DTA toxin. Hence, we based
the rest of the analysis in this paper on JDTA mice.
The Functional Capacity of the DTA Toxin Gene in the J
Chain Locus of JDTA Mice. A pertinent question to be
addressed in order to interpret the data obtained in the
JDTA model is the robustness of the model. To address
this question we reasoned that fusion of splenocytes to
SP2/0 plasmacytoma cells would result in hybridomas that
have the secretory phenotype of this J chain–expressing
fusion partner. To this end, we used B cells from wt, het-
erozygous JDTA, and JDTA mice stimulated with LPS for
48 h in order to increase fusion efficiency. These cell pop-
ulations were fused to SP2/0 and plated at various SP2/0
cell concentrations in 96-well plates. After conventional
selection procedures, the number of growing hybridomas
were scored (Fig. 2). When plating 20,000 SP2/0 cells
fused with wt B cells, hybridoma growth was detected in
virtually 100% of the wells, indicating that most wells con-
tained more than one growing clone according to Poisson
statistics. Hybridoma growth was reduced by 40% at this
SP2/0 cell density in the fusions with JDTA and JDTA
heterozygous B cells. In the plates where 5, 000 or 1,250
SP2/0 cells had been plated, the number of recovered hy-
bridomas from the fusion with B cells from JDTA mice
was greatly reduced. Furthermore, at inputs of SP2/0 cells
were limiting dilution conditions was established, 37%
negative wells according to Poisson statistics, the numbers
Figure 2. Functional activity of the DTA transgene. (A) In vitro activation of the DTA gene by cell fusion. Percentage of hybridoma growth from wt,
JDTA heterozygous (JDTA / ), and JDTA day 2 LPS-stimulated splenic B cells fused with SP2/0 and plated at different SP2/0 cell densities. (B) Dele-
tion of J chain–expressing cells in vivo. Serum IgA from wt, JDTA heterozygous, and JDTA mice were separated on a nondenaturating polyacrylamide
gel and detected by immunoblotting.562 J Chain Expression in B Cells
of recovered hybridomas from B cells from heterozygous
JDTA mice were intermediary to that of JDTA B cells.
This would be expected since the probability of incorpo-
rating one DTA-expressing allele in the hybridoma using
heterozygous B cells should be only 50% of that when ho-
mozygous B cells are used. Thus, we conclude that the ge-
netically manipulated JDTA locus is functional and has es-
sentially a 100% phenotypic penetrance, given the proper
intracellular environment.
To further establish that the DTA transgene was active
and deleted J chain–expressing B cells in vivo we purified
serum IgA from wt, heterozygous JDTA, and JDTA. After
separation on nondenaturing polyacrylamide gels the ex-
pression of dimeric and monomeric IgA was analyzed (Fig.
2 B). While the expression of dimeric IgA was dominating
in sera from wt mice, essentially no dimeric IgA was de-
tected in sera from JDTA heterozygous mice indicating a
complete deletion of J chain–expressing B cells. JDTA se-
rum also contained only monomeric IgA as expected since
both alleles of the J chain locus are inactivated in these ani-
mals. We conclude from these data that the presence of a
DTA gene on one allele suffice for the elimination of J
chain–expressing B cells in vivo.
JDTA Mice Have Perturbed Serum Ig Levels. It has been
claimed that all plasma cells in the mouse express J chain ir-
respective of which Ig isotype is expressed (30, 31). How-
ever, upon analysis it was evident that JDTA mice still had
significant levels of serum Ig (Fig. 3 A). The IgM and IgG
serum levels of JDTA mice were found to be reduced six
and eight times respectively when compared with wt con-
trols, while the serum IgA level was upregulated 14-fold in
JDTA mice.
We also analyzed Ig secretion in bone marrow and
spleen from JDTA mice at the single cell level using
ELISPOT (Fig. 3 B and C) The number of IgM- and IgG-
secreting cells per 106 lymphocytes in both organs were re-
duced in JDTA mice, as expected from the serum Ig levels.
On the other hand, the number of IgA-secreting cells per
106 lymphocytes was reduced in bone marrow but normal
in spleen when compared with wt controls. Taking into
account the increase in spleen size in JDTA spleen (wt:
80   24; JDTA: 114   23, all numbers  106 cells, n   12),
the total number of IgA-secreting cells per spleen was in
fact increased in JDTA mice compared with wt while IgM-
and IgG-secreting cells were reduced. More importantly,
since there were significant numbers of Ig-secreting cells
present in both spleen and bone marrow of JDTA mice, we
conclude that there exist populations of Ig-secreting cells
that have not activated the J chain locus. Finally, we also
analyzed the various B cell populations in spleen and bone
marrow using FACS® without finding significant alter-
ations of a distinct B cell subset (data not shown).
J Chain-Negative, Secretory B Cells Are Readily Detected in
wt Mice. A key observation in this study is that Ig-secret-
ing B cells either express the J chain locus or not. It could
be argued that in the genetically manipulated mice, a strong
selection pressure for rare populations of B cells was estab-
lished that is not paralleled in normal animals. Therefore,
we established a PCR analysis to detect the ratio between
the expression of RNA for secretory IgM ( s) over the
membrane form ( m) as an independent marker for secre-
tory B cells. Fig. 4 A shows the outcome of this assay using
a pre-B cell line, a B cell lymphoma cell line, and LPS-
stimulated spleen cells. In the clonal cell lines the  m/ s
ratio was close to 1, while in LPS-stimulated spleen RNA
the  s RNA is dominating due to the presence of IgM-
secreting plasma cells. It should be noted that J chain ex-
pression could easily be detected in both the pre-B and the
B cell lymphoma cell line, correlating with the situation
seen in cell lines representing early stages of human B cell
development (32–34). Then we proceeded to analyze the
correlation between dominant  s RNA expression and J
chain expression in single, LPS-stimulated cells from the
spleen of C57BL/6 mice. Fig. 4 B summarizes the results
obtained from 38 single B cells. While 26 cells showed an
abundance of  s expression, only 13 of these were positive
for J chain mRNA (Fig. 4 C show examples of the raw data
obtained). Thus, we conclude that also in wt mice B cells
with a secretory phenotype that do not express the J chain
locus can readily be detected and may constitute up to 50%
of this cellular compartment.
Introduction of a Distinct Coding Region in the J Chain Locus
Results in a Novel Phenotype. As a control for the JDTA
experiments we would also like to determine that targeting
a distinct open reading frame into the J chain locus would
result in a mouse strain that showed a distinct phenotype
Figure 3. Perturbed Ig production in the JDTA
mice. (A) Serum IgM, IgG, and IgA levels in wt and
JDTA mice at the age of 4 mo (n   5). Number of Ig-
secreting cells per 106 cells from wt and JDTA spleen
(B) and bone marrow (C) as detected by ELISPOT as-
say (n   3). Data shown from one out of three experi-
ments giving similar results. SFC, spot-forming cell.563 Erlandsson et al.
from JDTA and J /  mice. Hence, we made a DNA con-
struct based on the same principle as for constructing JDTA
mice, but where, instead of the DTA gene, a cDNA for the
c-myc oncogene was inserted (Fig. 5 A). ES cell clones were
obtained at a frequency of 1/40 and one clone was used to
generate JcMycneo mice, which had a J /  phenotype
(data not shown). To enable cMyc expression the JcMyc-
neo mice were bred to mice constitutively expressing the
Cre enzyme (42), enabling in vivo excision of the neomy-
cin cassette. JcMyc mice were identified by Southern blot
analysis on DNA from tail biopsies and backcrossed to
C57BL/6 mice (Fig. 5 A). The expression of the cMyc
gene from its position in the J chain locus was analyzed us-
ing a similar approach as for the DTA gene in JDTA mice
above. As shown in Fig. 5 B, expression of the exogenous
cMyc gene was readily detectable in both heterozygous Jc-
Myc mice and JcMyc mice. Litter sizes of the JcMyc mice
were normal and the offspring displayed a normal Mende-
lian distribution of wt, heterozygous, and homozygous
mice. The cell numbers of the JcMyc spleen as well as the
bone marrow were found to be normal when compared
with wt littermates (data not shown). JcMyc spleen cell
populations as well as bone marrow, thymus, and perito-
neal cell populations were analyzed using FACS® and no
significant differences when comparing to wt littermates
was detected (data not shown).
With regard to the levels of serum Ig in JcMyc mice,
both the total serum Ig (data not shown) and serum IgG
levels in JcMyc mice were normal when compared with wt
littermate controls (Fig. 5 C). The serum IgM levels of Jc-
Myc mice were found to be equal to those observed in wt
controls, in contrast to the situation in J /  mice (25),
while the serum IgA levels in the JcMyc mice was elevated
about sevenfold compared with wt (Fig. 5 C). We also per-
formed ELISPOT analysis on IgM-, IgA-, and IgG-secret-
ing cells in bone marrow and spleen from JcMyc mice
comparing them to wt littermates (Fig. 5 C). The number
of IgM- and IgG- secreting cells per 106 lymphocytes in
both spleen and bone marrow were normal, as expected
from the serum Ig. The number of IgA-secreting cells in
the JcMyc bone marrow was close to wt levels, while the
number of IgA-secreting cells in the spleen was increased
fivefold. We conclude from this experiment that the intro-
duction of a distinct coding sequence into the J chain locus
results in the generation of a mouse strain with a distinct
phenotype monitored at the level of Ig secretion.
Mice Devoid of J Chain–expressing Cells Are Partially Im-
mune Compromised. So far we had only investigated the
levels of background Ig but we also wanted to analyze the
humoral immune response in mice that can only produce J
chain-negative plasma cells. To this end, we immunized
JDTA mice with the T cell–dependent antigen 2-phenyl-
5-oxazolone coupled to OVA (phOx-OVA). Serum was
taken 14 and 45 d after primary immunization. As shown
in Fig. 6 A, the levels of total phOx-specific antibodies
were reduced about sixfold at day 14 of the primary re-
sponse to this antigen, while only twofold at day 45 of the
response. Fig. 6 B shows the levels of phOx-specific IgM
and IgG antibodies at day 14, and both were reduced. We
conclude from these data that JDTA mice are immune
competent although immune compromised especially at
early time points during the immune response.
To validate the finding in JDTA mice we also immu-
nized JcMyc mice with phOx-OVA and analyzed serum
anti-phOx antibodies at day 14 after immunization. The
immune response in the JcMyc mice was quite distinct
from that seen in JDTA mice. Hence, the level of phOx-
specific IgM and IgG antibodies were similar, or even
slightly increased, compared with wt levels (Fig. 6 C).
Next we analyzed if the JDTA mice were immune com-
petent in the LP of the gut mucosa. After three oral immu-
nizations with CT we analyzed the specific CT response in
JDTA and wt mice (Table I). As the J /  mice, the JDTA
mice had undetectable levels of anti-CT IgA in gut lavage,
which was expected since they cannot transport IgA across
the mucosal surface due to the absence of J chain (24, 27).
When analyzing the anti-CT total Ig or anti-CT IgA con-
Figure 4. Single cell analysis of J chain expression in secretory B cells
from wt mice. (A) RT-PCR analysis of J chain and secretory versus
membrane bound IgM expression in two different murine cell lines and
in LPS-stimulated total splenocytes representing different differential
stages of B cell development. 230–238 represents a pre-B, A20 represents
a mature B cell, and the LPS-stimulated total spleen represents the plasma
cell stage. (B) Summary of single cell RT-PCR analysis of J chain and
secretory IgM transcripts in LPS-stimulated splenic B cells. (C) Example
of experimental data showing one example of a single cell expressing only
secretory IgM and of a single cell expressing both J chain and secretory
IgM. HPRT is used as a cDNA control.564 J Chain Expression in B Cells
Figure 5. Replacement of the J chain
exon 1 with the cMyc gene and Ig produc-
tion in the resulting JcMyc mice. (A) Dis-
ruption of the J chain gene and gene re-
placement by homologous recombination.
Genomic map of J chain locus before and
after homologous recombination. Diges-
tion with KpnI gives an endogenous band
of 5.6 kb while the recombined locus gives
a band of 8.8 kb for JcMycneo and 7.0 kb
for JcMyc after removal of the neor gene.
Southern blot analysis of the recombined J
chain locus showing wt, heterozygous ( / )
JcMycneo, and heterozygous ( / ) JcMyc
using an outside probe (not present in the
construct used for targeting). E, EcoRI; B,
BamHI; S, SacI; P, PstI; K, KpnI; and H,
HindIII. (B) Expression analysis by RT-PCR
for J chain and cMyc transcripts in wt, JcMyc
heterozygous (JcMyc / ), and JcMyc mice.
Primers for J chain were located in exon 1
and in exon 4 of the J chain locus. Primers
for cMyc transcripts were located in the 3 
end of the cMyc gene and in the exon 4 of
the J chain locus. Shown is also analysis for
HPRT transcripts as a cDNA control. (C)
Serum IgM, IgG, and IgA levels in wt and
JcMyc mice at the age of 4 mo (n   3) and
number of Ig-secreting cells per 106 cells
from wt and JcMyc spleen and bone mar-
row as detected by ELISPOT assay (n   3).
Data shown from one out of two experi-
ments giving similar results. SFC, spot
forming cell.
Figure 6. Humoral immune response in JDTA and JcMyc
mice. (A) wt and JDTA mice were immunized with 100  g
of phOx-OVA intraperitoneally (n   5) at the age of 4 mo.
Sera were collected at day 14 and day 45 after immuniza-
tion and total anti-phOx–specific antibodies were analyzed
by ELISA. Data shown from one out of two experiments
giving similar results. (B and C) wt, JDTA (B), and JcMyc
(C) mice were immunized with 100  g of phOx-OVA
intraperitoneally (n   5) at the age of 4 mo. Sera were
collected at day 14 after immunization and IgM and IgG
anti-phOx–specific antibodies were analyzed by ELISA.
Data shown from one out of two experiments giving
similar results.565 Erlandsson et al.
tents in serum we found total Ig to be unaltered and anti-
CT IgA near normal or slightly increased when compared
with wt (Table I). Furthermore, detection of anti-CT–spe-
cific antibody-producing cells in the LP of immunized
JDTA mice showed a 75% reduction in numbers of anti-
CT IgA-secreting cells when compared with wt controls.
Thus, the introduction of an exogenous gene into the J
chain locus will qualitatively and quantitatively alter the
immune response to a defined antigen.
Commitment to J Chain Expression Is an Early Event during
B Cell Differentiation. Our data indicates that once B cells
are committed to secrete Ig at a high rate, they either ex-
press J chain or not. However, it cannot be excluded that J
chain expression is a clonal property decided before the B
lymphocyte reaches the terminal developmental stage of
high Ig secretion. Evidence in favor of early commitment
to Ig secretion can be found in the observation that some
human cell lines and normal cells representing early stages
of B cell development have been shown to express the J
chain locus (32–35). We confirmed this finding using a
panel of mouse B cell lines and RT-PCR (Fig. 7). The
plasmacytoma J558 and total spleen cells expressed high
levels of J chain RNA as expected. However, the B cell
lymphomas WEHI231, A20, and K46R also expressed de-
tectable levels of J chain RNA, as did the Abelson trans-
formed pre-B cell lines 18–81 and 230–238. Interestingly, J
chain transcripts were undetectable in the pre-B cell line
70Z/3 both before and after stimulation with LPS.
To expand this analysis to untransformed B cells we
performed limiting dilution analysis of LPS-stimulated
C57BL/6 splenic lymphocytes (Fig. 8). To reduce back-
ground in the subsequent PCR analysis the limiting dilu-
tion assay was performed in the absence of filler cells, and
only 1 out of 25 cells plated gave rise to an Ig-positive well
under our experimental conditions (Fig. 8 A). Individual
wells that were Ig-positive and derived from a single pre-
cursor clone according to the Poisson distribution, were
subsequently analyzed for HPRT and J chain mRNA ex-
pression using RT-PCR (Fig. 8 B). Under these experi-
mental conditions, HPRT mRNA could be detected in
 50% of the Ig  wells but only between 20–50% of these
HPRT-positive wells were also positive for J chain mRNA
(Table II). No wells were found that were positive for J
chain RNA and did not express HPRT mRNA. We con-
clude from this experiment that J chain expression is a
clonal property of peripheral B lymphocytes already before
they are committed to Ig secretion.
Discussion
The goal with the current investigation was to directly
address the heterogeneity of plasma cell populations in
mice using J chain expression as a marker. Hence, while it
has been claimed, and widely accepted, that all plasma
cells in the mouse express the J chain locus (30, 31) de-
tailed studies have been hampered by the absence of ro-
bust serological reagents for detection of J chain protein.
In humans such reagents exist and have been used to cor-
relate J chain expression and plasma cell differentiation.
Thus, it has been shown in human systems that there was
Table I. Anti-CT Titers in Lavage and Serum, and Numbers of Anti-CT–specific Secreting Cells in LP from Immunized wt and
JDTA Micea
Genotye
Lavage
anti-CT IgA
Serum
anti-CT total Ig
Serum
anti-CT IgA
Anti-CT
IgA-secreting cellsb
Log10 titer Log10 titer Log10 titer
wt 2.5   0.2 4.7   0.1 3.7   0.4 16,000   4,770
JDTA  1.0 4.5   0.1 4.1   0.2 3,792   617
aSix mice of each genotype were given three oral doses of CT (10  g/dose) and killed 6 d after the final immunization. Data shown are from one
out of two experiments giving similar results.
bNumbers of anti-CT IgA-secreting cells per 107 LP cells detected by CT-specific ELISPOT.
Figure 7. RT-PCR analysis of J chain expression in mouse cell lines representing various stages of B cell differentiation. RT-PCR analysis was per-
formed as described previously. The 70Z/3 cell line was analyzed both unstimulated but also after 24 and 40 h stimulation with LPS which triggers its
differentiation to a surface Ig  phenotype, as indicated.566 J Chain Expression in B Cells
a positive correlation between the production of poly-
meric IgA and the presence of cytoplasmic J chain; tissues
that produced predominantly monomeric IgA generally
displayed fewer cells containing cytoplasmic J chain (37,
40). Furthermore, tissues associated with mucosal surfaces
provide a greater proportion of polymeric IgA than other
lymphoid tissues, whereas bone marrow, spleen, and
lymph nodes produce mostly monomeric IgA (37, 39, 40).
In addition, it has been shown that 50–70% of the IgG-
secreting cells in human glandular tissue or in activated
germinal centers are J chain-positive (39, 48). In contrast,
only a small percentage of the IgG- secreting cells in extra
follicular sites or in chronic foci of inflammation contain
detectable J chain (39, 48). In studies of IgA M compo-
nents it was noted that the most common ratio of J chain
over IgA was 0, rather than the value of 0.5 expected from
dimeric IgA (49); a finding that also would implicate that
myelomas may arise in J chain-negative and in J chain-
positive plasma cells.
We show that mice where J chain–expressing B cells are
deleted still have serum Ig and can mount specific humoral
immune responses to T cell–dependent antigens. Although
clearly immune compromised the phenotype of JDTA mice
was not dramatic. We would explain this by considering
the complexity of the regulatory circuits involving serum Ig
(5, 50). On the other hand, we are well aware of that our
experimental approach is highly dependent on the reliable
expression of DTA and subsequent deletion of the proper
cells. To verify this we detected DTA mRNA expression in
LPS-stimulated cells from JDTA mice originating from the
genetically altered J chain locus. Furthermore, the func-
tional deletion properties of the DTA-containing J chain
locus was verified by the selective deletion of hybridomas
generated from JDTA mice which was gene-dosage depen-
dent, and the finding that in serum from mice heterozygous
for the DTA transgene no dimeric IgA could be detected.
As a further verification we integrated a c-myc cDNA se-
quence into the J chain locus and generated a separate
mouse strain. These mice had a subtle but easily detectable
phenotype distinct from JDTA mice. All in all, we consider
that our experimental system has been properly validated
and can be used as a reliable base for our conclusions.
One major conclusion from this study is that plasma cells
can be separated into two subsets based on J chain expres-
sion. This finding also has bearing on the generation of se-
rum IgA. While being mostly associated with mucosal im-
mune responses, IgA is also a common serum Ig isotype
and the bone marrow of humans contain high numbers of
IgA plasma cells (37, 40, 51). In addition, the bulk of se-
rum IgA in humans is monomeric (37, 51), while there
seems to be a 1:1 relationship between monomeric and
dimeric IgA in mouse serum (52). One model to explain
this distribution would be that IgA-producing plasma cells
are unable to efficiently assemble dimers and hence the
same cell that produce dimeric IgA would also secrete a
significant amount of monomeric IgA. Since only J chain–
containing, dimeric IgA would be transported over the
mucosal lining (24, 53), the monomeric IgA would as a
Figure 8. Limiting dilution analysis on LPS stimulated wt C57BL/6
splenic lymphocytes at day 7. (A) Fraction of Ig-negative wells plotted
against number of cells seeded per well. The intercept between the 0.37
fraction of negative wells and the linear distribution of the samples gives
the limit of clonality, according to the Poisson distribution. One repre-
sentative plot out of three experiments is shown. (B) Expression analysis
by RT-PCR for HPRT and J chain on Ig-positive wells.
Table II.
Frequency J  Percentage J 
Exp. 1  5/24 21
Exp. 2 11/21 52
Exp. 3 3/15 20
One representative experiment out of three is shown. The frequency of J
chain–expressing clones is from three independent experiments. Exp.,
experiment.567 Erlandsson et al.
consequence accumulate in the serum. The experiments
presented herein excludes that this model is exclusive (40),
and conclusively show that the production of monomeric
and dimeric IgA can be clonally distributed. Especially
compelling in this context was the finding that serum IgA
levels were even elevated in JDTA mice, while the gut im-
mune response was compromised. That some IgA-secret-
ing cells in normal mice produce monomeric and dimeric
IgA carrying the same paratope cannot be formally ex-
cluded by our studies. However, it should be remembered
that in humans the  2 heavy chain gene seems to be used
preferentially in dimeric IgA, while the  1 heavy chain
gene dominates in monomeric serum IgA (51, 54). This
finding would support the notion of a clonal separation of
the production of these two IgA forms that in turn seems
to correlate with J chain expression.
The elevation of serum IgA observed in J /  mice,
JDTA mice, and in JcMyc mice merits discussion (for a
summary of the phenotypes see Table III). The conclusion
drawn from the situation in J /  mice, that the high serum
IgA levels was a consequence of impaired polyIgR-medi-
ated transport of IgA in the absence of J chain (24) can now
be extended. Part of this phenomenon could also be due to
a compensatory mechanism for the reduced serum IgM
levels in these mice. The same population of B cells/plasma
cells seems to be responsible for the upkeep of both serum
IgM and serum IgA levels (55, 56), and it can be envi-
sioned that the low IgM levels would trigger an increased
IgA production from the same subset via unknown ho-
meostatic mechanisms (5, 50). In addition, it has been
shown that the IgM detected by ELISA in these mice is of
heterogeneous stoichiometry (25). This observation, taken
together with the accentuated IgA production seen in Jc-
Myc mice where the IgM level is normal, would indicate
that what is regulated is the level of pentameric (or poten-
tially hexameric) IgM. These interesting questions with re-
gard to regulation of serum Ig homeostasis can now be fur-
ther explored using the experimental models described
herein. With regard to the other Ig isotypes, the reduced
IgM level in JDTA mice was similar to that observed in J / 
mice (25), while serum IgM levels were at wt levels in
JcMyc mice. This would indicate that the expression of
c-myc from its position in the J chain locus positively selects
these plasma cells and compensates for the reduced IgM
levels seen in J /  mice. In addition, IgG levels were also
reduced in JDTA mice, indicating that a significant amount
of serum IgG in normal mice is generated from the J chain–
expressing B cell linage. Hence, the notion that commit-
ment to J chain expression is independent of Ig heavy chain
isotype expression was confirmed (30, 57).
The humoral immune response (IgM and IgG) seen in
JDTA mice after immunization with a T cell–dependent
antigen was significantly reduced at day 14 after immuniza-
tion. However, at day 45 a significant level of serum anti-
bodies specific for the antigen could be detected. In sepa-
rate studies we also immunized the JDTA mice with a T
cell–independent antigen and obtained similar results (data
not shown). As a comparison, the IgM and IgG immune
response seen in the JcMyc mice was similar to wt controls
at day 14. From these results one may speculate that J
chain–expressing plasma cells could be more prominent in
Ig production during the early phases of the immune re-
sponse (day 14), while the long-lasting Ig production seen
at later stages might be more influenced by J chain-negative
plasma cells (11, 12, 15).
From the same line of reasoning it would also follow that
long-term antibody secretion, and hence immunity depen-
dent on persisting antibody on mucosal surfaces, would be
hard to achieve in the gut where the effector plasma cells
by necessity must be J chain producing (24). Supporting
this is the finding in JDTA mice immunized orally with
CT where the serum anti-CT IgA levels were nearly nor-
mal, while the number of anti-CT IgA-secreting cells in
the LP of the intestine was reduced. Only  25% of the
anti-CT IgA-secreting cells were left in the LP of JDTA
mice. In contrast, the same experiment made in J /  mice
showed that the number of anti-CT IgA-secreting cells in
the LP was normal (27, Table III).
The last question asked relates to the timing of commit-
ment to J chain expression. It has been claimed that J chain
transcription was an exclusive marker for plasma cell differ-
entiation (30, 31), but in later studies J chain RNA has
been detected in early B cells in humans (35). We also
show here that this is true using transformed mouse B cell
lines. To confirm our conclusion concerning the presence
of J chain–expressing and –nonexpressing plasma cells we
performed single cell PCR analysis of LPS-stimulated B
cells from normal C57BL/6 mice. We here used the shift
of IgM transcript to the secretory form as an independent
control for commitment to secretion. From this experi-
ment it was evident that among IgM-expressing B cells
there is a significant fraction that does not express the J
chain locus. It should also be noted that monomeric IgM,
in contrast to IgA, is never detected in serum of healthy in-
dividuals due to regulation during the assembly process,
again hinting towards a critical function for pentameric/
Table III. Summary of Mouse Strains with Disrupted J
Chain Locus
JDTA JcMyc J / 
Serum Ig    /   / 
Serum IgM    /  
Serum IgG    /   / 
Serum IgA        
LP SFC   ND  / 
BM SFC    /  
Spleen SFC     
Systemic IR      / 
Gut   ND  
 , increased;  , decreased;  / ; unchanged; IR, immune response;
and SFC, spot-forming cell.568 J Chain Expression in B Cells
hexameric IgM (58). Thus, J chain-negative plasma cells
could be generated in normal individuals without the pres-
ence of IgM monomers in serum. Whether the hexameric
IgM observed in serum (59, 60) is produced by J chain-
negative plasma cells remains an open question.
We further extended our analysis to the clonal level of
splenic B cells using a limiting dilution approach. Using
this analysis we could show that J chain expression was a
clonal property of single splenic B cells, indicating that the
commitment to J chain expression is already established in
LPS-reactive, splenic B cells. This somewhat surprising re-
sult is compatible with earlier observations where J chain
RNA expression has been detected in human pre-B cells
(35). It also brings into question the mechanism for activa-
tion/silencing of the J chain locus and indicates that this
might be an early event during B cell differentiation. It
should here be remembered that the J chain promoter re-
gion resembles Ig light chain promoters (61), and that a
similar molecular machinery as that used for allelic exclu-
sion of the Ig loci might also operate on the J chain locus.
In summary, we have shown that two different B cell
lineages can be defined with regard to their ability to ex-
press J chain. The functional differences between these two
B cell populations remains to be analyzed in detail but one
may speculate that longevity, response to different signals,
and homing properties might differ. The rational for the
existence of these two B cell lineages is unclear. It is tempt-
ing to speculate that J chain–expressing, Ig-secreting cells
were imperative early in evolution when local immune re-
sponses to protect the host against microbes in the digestive
tract was the dominant feature of the immune system. In-
deed, J chain expression has been detected in evolution be-
fore the presence of Ig (36), and it can be speculated that Ig
was not the first molecule to be transported by the J chain/
polyIg receptor system. As evolution generated more re-
fined, multicellular organisms systemic immunity and se-
rum Ig started to play a role and it became pertinent that
not all Ig produced was transported out onto mucosal sur-
faces. A stochastic mechanism that generates a certain frac-
tion of Ig-producing cells unable to produce J chain would
be a mechanism to ensure this balance.
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